5 Best Bargain Stocks to Buy in August

2. Gilead Sciences, Inc. (NASDAQ:GILD)

Number of Hedge Fund Holders: 60

Upside Potential as of August 1: 19.94%

Average Price Target: $91.14

Gilead Sciences, Inc. (NASDAQ:GILD) is a biotechnology company developing medicines in the areas of unmet medical needs. It is based in Foster City, California.

A total of 60 hedge funds were long Gilead Sciences, Inc. (NASDAQ:GILD) in the first quarter, with a total stake value of $3.9 billion.

Piper Sandler’s Joseph Catanzaro holds an Overweight rating and a $100 price target on Gilead Sciences, Inc. (NASDAQ:GILD) shares as of July 24.

Follow Gilead Sciences Inc. (NASDAQ:GILD)